Abstract: Embodiments of a condition monitoring system and method provide an interface with visual aids that facilitate diagnosis of problems on an asset (e.g., a turbine, motor, pump, etc.). In one embodiment, the visual aids display fault data that corresponds to a fault condition such as bearing failure and/or shaft misalignment. The fault data is collected by sensors on the asset and processed by the condition monitoring system for use with the interface. In one example, the interface can include one or more icons, which represent fault conditions for the asset, and which an end user may select to display the visual aids on the interface. Selection amongst the different icons will change the visuals aid, the fault data, and other aspects of the interface to enable diagnosis and promote effective maintenance of the asset.

Abstract: A power generation plant including a plurality of combustor cans, one or more sensors configured to measure acoustic vibrations from the plurality of combustor cans, and a controller that includes a processor. The processor is programmed to identify a dominant tone of the measured acoustic vibrations, the dominant tone being a frequency where a highest amount of energy lies, determine, for each of the plurality of combustor cans, a frequency of the dominant tone at predefined time intervals, and determine a degradation status of at least one of the plurality of combustor cans based on the frequency of the dominant tone at each of the predefine time intervals for the at least one of the plurality of combustor cans.

Abstract: The present invention relates to a novel chemical compound for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Abstract: A device for use in monitoring operation of a system asset includes a display device and a processor coupled to the display device. The processor is configured to display a first plot of a first operation characteristic of the system asset as a function of a second operation characteristic in response to a user selection to display the first plot, display a reference graphical plot of the first operation characteristic of the system asset as a function of the second operation characteristic overlying the first plot, and maintain the display of the reference graphical plot on the display device when the user selects a second plot. The reference graphical plot is displayed overlying the second plot.

Abstract: The present invention relates to a novel chemical compound of formula S-(1): for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Abstract: Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.

Abstract: A power generation plant including a plurality of combustor cans, one or more sensors configured to measure acoustic vibrations from the plurality of combustor cans, and a controller that includes a processor. The processor is programmed to identify a dominant tone of the measured acoustic vibrations, the dominant tone being a frequency where a highest amount of energy lies, determine, for each of the plurality of combustor cans, a frequency of the dominant tone at predefined time intervals, and determine a degradation status of at least one of the plurality of combustor cans based on the frequency of the dominant tone at each of the predefine time intervals for the at least one of the plurality of combustor cans.

Abstract: Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.

Abstract: Embodiments of a condition monitoring system and method provide an interface with visual aids that facilitate diagnosis of problems on an asset (e.g., a turbine, motor, pump, etc.). In one embodiment, the visual aids display fault data that corresponds to a fault condition such as bearing failure and/or shaft misalignment. The fault data is collected by sensors on the asset and processed by the condition monitoring system for use with the interface. In one example, the interface can include one or more icons, which represent fault conditions for the asset, and which an end user may select to display the visual aids on the interface. Selection amongst the different icons will change the visuals aid, the fault data, and other aspects of the interface to enable diagnosis and promote effective maintenance of the asset.

Abstract: The present invention relates to a novel chemical compound of formula S-(1): for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Abstract: The present invention relates to a novel chemical compound of formula S-(1): for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Abstract: Provided herein are compounds and methods for the treatment of brain cancer in a mammal, wherein the method comprises the administration to the mammal a compound that stabilizes tubulin dimers or microtubles at G2-M interface during mitosis but is not a substrate for MDR protein. In particular, the present application relates to the use of an orally effective abeo-taxane, alone or in combination with temozolomide or bevacizumab, for the treatment of brain cancer.

Abstract: The present invention relates to a novel chemical compound of formula S-(1): for use in the treatment of cancer, to compositions containing said compound, methods of manufacture and combinations with other therapeutic agents.

Abstract: Retroviral vectors which encode interferon alpha are disclosed. These canbe used to produce recombinant transduced cells. Both the vectors and the recombinant transduced cells can be used therapeutically. The cells can also be used to produce alpha interferon.